Pulse Biosciences Inc (PLSE)

Mar 31, 2026

PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN

Mar 31, 2026

Mar 31, 2026

Pulse Biosciences Shifts Focus to Catheter Electrophysiology Tech - Medical Product Outsourcing

Mar 31, 2026

Mar 30, 2026

How Pulse Biosciences’ nPulse AFib Refocus Will Impact Pulse Biosciences (PLSE) Investors - simplywall.st

Mar 30, 2026

Mar 30, 2026

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7%What's Next? - MarketBeat

Mar 30, 2026

Mar 29, 2026

PLSE Stock News Today | Earnings, Events & Price Alerts - intellectia.ai

Mar 29, 2026

Mar 28, 2026

Pulse Biosciences, Inc. 8-K SEC Filing March 23, 2026 – Company Information, NASDAQ Listing, and Key Details - Minichart

Mar 28, 2026

Mar 27, 2026

Pulse Biosciences Grants RSUs to Chief Technology Officer - TipRanks

Mar 27, 2026

Mar 27, 2026

Pulse Biosciences (NASDAQ: PLSE) awards CTO 100,000-share RSU grant - Stock Titan

Mar 27, 2026

Mar 26, 2026

PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data - sharewise.com

Mar 26, 2026

Mar 26, 2026

PLSE Speeds Up Cardiac Catheter Initiative Following Landmark AFib Findings - Bitget

Mar 26, 2026

Mar 25, 2026

Stock Analysis: Is Pulse Biosciences Inc exposed to currency risks2026 Short Interest & Risk Managed Trade Strategies - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

(PLSE) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Mar 24, 2026

Mar 24, 2026

Pulse Biosciences to accelerate Pulse Cardiac Catheter Ablation System - msn.com

Mar 24, 2026

Mar 23, 2026

Assessing Pulse Biosciences (PLSE) Valuation After The nPulse Cardiac Catheter Ablation Pivot - Sahm

Mar 23, 2026

Mar 21, 2026

Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study - Yahoo Finance

Mar 21, 2026

Mar 20, 2026

PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill

Mar 20, 2026

Mar 19, 2026

What's Going With Pulse Biosciences Stock On Monday? - MSN

Mar 19, 2026

Mar 18, 2026

Pulse Biosciences targets CE mark submission in 2026 as nPulse platform advances clinical milestones - MSN

Mar 18, 2026

Mar 18, 2026

Pulse Biosciences at Oppenheimer Conference: Promising AF Ablation Results By Investing.com - Investing.com India

Mar 18, 2026

Mar 18, 2026

Pulse Biosciences (NASDAQ:PLSE) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Mar 18, 2026

Mar 18, 2026

Pulse Biosciences (PLSE) Is Up 14.8% After Refocusing On nPulse AFib Catheter PlatformHas The Bull Case Changed? - simplywall.st

Mar 18, 2026

Mar 18, 2026

Pulse Biosciences shifts focus to cardiac catheter program By Investing.com - Investing.com South Africa

Mar 18, 2026

Mar 17, 2026

Pulse Biosciences Announces Organizational Realignment to Accelerate Cardiac Catheter Program After Exceptional AFib Clinical Results - Minichart

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences Realigns Strategy Around nPulse AFib Platform - TipRanks

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences (PLSE) realigns strategy around nPulse AFib catheter program - Stock Titan

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data - BioSpace

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program - marketscreener.com

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences (PLSE) Prioritizes nPulse Cardiac Catheter Dev - GuruFocus

Mar 17, 2026

Mar 17, 2026

Pulse Biosciences shifts focus to cardiac catheter program - Investing.com

Mar 17, 2026

Mar 16, 2026

Is Pulse Biosciences’ (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? - Yahoo Finance

Mar 16, 2026

Mar 16, 2026

A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins - Yahoo Finance

Mar 16, 2026

Mar 16, 2026

Pulse Biosciences enrolls first patients in thyroid cancer study - Investing.com Nigeria

Mar 16, 2026

Mar 14, 2026

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And DCF Estimate Gap - simplywall.st

Mar 14, 2026

Mar 13, 2026

Responsive Playbooks and the PLSE Inflection - Stock Traders Daily

Mar 13, 2026

Mar 13, 2026

A Look At Pulse Biosciences (PLSE) Valuation After Recent Share Price Swings - Sahm

Mar 13, 2026

Mar 13, 2026

Pulse Biosciences enrolls first patients in thyroid cancer study By Investing.com - Investing.com Canada

Mar 13, 2026

Mar 12, 2026

Pulse Biosciences Launches Thyroid Cancer Feasibility Study - TipRanks

Mar 12, 2026

Mar 12, 2026

Pulse Biosciences, Inc. Announces First Enrollments in Feasibilit - The National Law Review

Mar 12, 2026

Mar 12, 2026

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology - The Joplin Globe

Mar 12, 2026

Mar 10, 2026

Pulse Biosciences (NASDAQ:PLSE) Trading 8% HigherWhat's Next? - MarketBeat

Mar 10, 2026

Mar 10, 2026

Breakout Move: Can Pulse Biosciences Inc continue delivering strong returnsMarket Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 10, 2026

Mar 10, 2026

Durable Thyroid Nodule Ablation Data Could Be A Game Changer For Pulse Biosciences (PLSE) - Sahm

Mar 10, 2026

Mar 09, 2026

Pulse Biosciences (PLSE) Reports Promising Long-Term Outcomes fo - GuruFocus

Mar 09, 2026

Mar 09, 2026

Pulse Biosciences Earnings Call: Data Strength Vs. Cash Burn - TipRanks

Mar 09, 2026

Mar 09, 2026

Pulse Biosciences Announces Long-Term Clinical Data for nPulse Vybrance Percutaneous Electrode System in Benign Thyroid Nodule Ablation 71314 - Minichart

Mar 09, 2026

Mar 09, 2026

Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation - Investing News Network

Mar 09, 2026

Mar 09, 2026

Pulse Biosciences Reports Durable Thyroid Nodule Ablation Results - TipRanks

Mar 09, 2026